Will Insurance Cover Ozempic for Prediabetes?

Will insurance cover Ozempic for prediabetes? Usually not. Ozempic — the shot and the newer Ozempic pill — is FDA-approved only for adults with type 2 diabetes. The table's prior-authorization criteria require that diagnosis. A documented type 2 diagnosis or another use your plan covers changes Ozempic's coverage question; Wegovy opens a separate weight-management path.

If you qualify for Medicare's GLP-1 Bridge, Wegovy costs $50 per monthly fill. First, here's exactly what the plans say in writing — then a quick finder to show which door to ask about.

RX Index Decision Verdict: For prediabetes alone, don't spend weeks fighting for Ozempic. Ask your plan which door your diagnosis and weight actually open.

• Best for: Adults with prediabetes who have a prescription, a denial, or a doctor who mentioned Ozempic.
• Not ideal for: People already diagnosed with type 2 diabetes. Your question is about the regular Ozempic rules, which our general Ozempic coverage guide covers.
• The factor that matters most: Whether your plan covers the exact medicine for the diagnosis in your chart — not how close your A1C is to 6.5%.

Will insurance cover Ozempic for prediabetes under these policies?

The Ozempic prior-authorization criteria below require type 2 diabetes. Ozempic's approved jobs all involve that diagnosis, but a plan can have its own rules for off-label use — a use outside the FDA label — and claims processing. Cigna lists prediabetes as not covered; the historical Express Scripts template recommends against approval for it.

Think of prior authorization as a permission slip from your insurer. Your doctor fills it out, and the plan checks it against its rules. For Ozempic, the box that matters says "type 2 diabetes." Prediabetes doesn't check it.

We checked these published examples from five insurers and pharmacy benefit managers on October 17, 2026 — six documents in all. The Express Scripts file is a historical template; its date matters:

These are published examples, not a check of your benefits. Employers can customize their plans, so ask for the policy that applies to your exact plan and medicine. A benefit manager runs a plan's drug coverage; its public template may not be the rule your employer chose.

The pill doesn't add an approved use for prediabetes. Ozempic tablets are also FDA-approved only for adults with type 2 diabetes (Ozempic tablets label). Your plan can have different rules for the shot and pill, so ask about the exact form.

Find your coverage door

Your documented diagnosis, your weight history, and your type of insurance decide which door is realistic. This finder doesn't predict approval. It tells you which question to ask, who to ask, and which costs you still need to confirm.

Plain example: Say you're 52, your doctor has diagnosed prediabetes but never type 2 diabetes, your A1C is 6.1%, your BMI is 31, and you have insurance through work. The finder says Door 2. Ozempic will likely be denied because you don't have a type 2 diagnosis. But your weight is in the usual range for a weight-management prescription. Your next step is to ask your plan one question: "Do you cover weight-loss medicines like Wegovy?"

The right next step isn't the same for everyone. It depends on your state, your insurance and its drug list, whether you want an FDA-approved shot or pill, and your budget. If you'd like help sorting that out, The RX Index's Find My GLP-1 Path tool asks a few quick questions and shows the GLP-1 paths and providers that fit your situation. It's free, takes about 2 minutes, and needs no signup.

See which GLP-1 path fits you

What A1C does insurance need for Ozempic?

For a type 2 diabetes request, plans want a documented diagnosis, not one A1C number. An A1C of 6.5% or higher is in the diabetes range, and 5.7% to 6.4% is in the prediabetes range. A clinician confirms and classifies the diagnosis; without clear evidence of diabetes, confirmation needs two abnormal results.

A1C is a blood test that shows your average blood sugar over the past few months.

Source: ADA Standards of Care in Diabetes—2026, Section 2. The fasting test follows at least eight hours without calories; the OGTT uses a 75-gram glucose drink. UnitedHealthcare and Aetna use these same diabetes cutoffs in their Ozempic policies.

A 6.3 or 6.4 can feel unfair. You're close. But plans run on categories, not "almost." This isn't a reason to wait until you get worse — often a better door is open right now.

Does trying metformin change the answer?

A metformin trial does not establish type 2 diabetes. Metformin is a common, low-cost diabetes pill. Some plans require you to try it first, which is called step therapy. In Aetna's policy, that's a second rule stacked on top of the diagnosis rule, not a way around it.

Aetna's policy is the clearest example. It asks for type 2 diabetes and one more item, such as metformin not working. Documented metformin failure or intolerance can check the second box. Taking metformin alone does not check the first. And no one should take a medicine just to build an insurance record — real intolerance belongs in your chart because it really happened.

One wrinkle: the CVS Caremark template can process some claims using past medicine or supply claims before asking for prior authorization. UnitedHealthcare also allows automated approval based on claim history or diagnosis codes; the older Express Scripts template has a medicine-history screen too. That can explain why someone else's prescription went through. It does not establish that your plan covers Ozempic for prediabetes.

What if my A1C dropped after a type 2 diabetes diagnosis?

A better A1C doesn't erase a diagnosis your doctor already made. The policies we read include ways to document that history. Aetna's renewal rules require qualifying past A1C or glucose results, plus either an A1C drop or one of its listed health conditions. They also require at least three months on a stable maintenance dose. UnitedHealthcare accepts chart notes confirming the diagnosis for people diagnosed more than two years ago.

If you were diagnosed with type 2 diabetes and now your numbers look like prediabetes, ask your doctor to send your original labs with the renewal. That's a different situation from never having been diagnosed.

Is Wegovy covered when Ozempic isn't?

Wegovy can be covered for weight management when Ozempic's diabetes rule is not met — if your plan covers that use and you meet its criteria. Wegovy has the same active ingredient as Ozempic: semaglutide. Wegovy is approved for weight management in adults with obesity, or overweight plus a weight-related health problem.

Sources: Ozempic injection label, Ozempic tablet label, Wegovy label, the policies above, and CMS's Bridge rules. Checked October 17, 2026. MASH is a liver disease involving fat, inflammation, and damage; Wegovy's injection indication is for adults without cirrhosis who have moderate to advanced liver scarring (F2–F3).

Here's why the drug name matters. The STEP 10 trial tested semaglutide 2.4 mg by weekly injection — used in standard Wegovy treatment — in adults with obesity and prediabetes. Both groups got diet and activity counseling. At 52 weeks, 81% met the study's blood sugar target, compared with 14% on placebo. That target was an A1C below 6.0% and fasting glucose below 5.5 mmol/L (about 99 mg/dL), which differs from the ADA cutoffs above. That's a study result in that group, not an FDA approval for prediabetes and not a promise for you.

Quick check: Is your BMI 30 or higher — or 27 or higher with a weight-related health problem? Those are the usual starting points for a prescription, according to NIDDK. At BMI 27–29.9, ask whether your plan counts prediabetes as that health problem; don't assume it does or doesn't. Plans can set stricter rules. BMI is a number based on your height and weight; our BMI chart shows where you land. For the full Wegovy rules, see our Wegovy-for-prediabetes coverage guide.

No web page, including this one, can tell you if you'll be approved. Your plan decides, and a licensed clinician decides if a medicine is right for you. What you can do is find out fast.

If you have insurance through work, the marketplace, or a federal employee (FEHB) plan, Ro's free coverage checker checks the Ozempic pen, Wegovy pen, and Zepbound autoinjector pen. It asks for your name and insurance details and sends a report; it does not request treatment or approve coverage. It does not list Ozempic tablets and cannot check the Wegovy pill, Foundayo pill, or Zepbound KwikPen.

If you want care as well, Ro's treatment quiz is the next step below. If you become a member and a provider prescribes, Ro's team handles the prior authorization paperwork and can appeal a denial. Membership starts at $39 for the first month, with medicine billed separately. Ro's insurance help doesn't work with Medicare or Medicaid.

Explore your options with Ro

Does Medicare cover Ozempic for prediabetes?

Usually not for prediabetes alone. The two Medicare plan policies we checked do not list it as an Ozempic approval path. Ozempic isn't part of Medicare's GLP-1 Bridge, either. But the Bridge can cover Wegovy, the Zepbound KwikPen, and Foundayo for $50 per monthly fill for eligible people whose BMI was 27 or higher with documented prediabetes when treatment started.

Your exact plan still matters. Univera's October 2026 Medicare criteria cover type 2 diabetes and allow review under Medicare's off-label rules. Mass General Brigham Medicare Group Rx (PDP) also lists an Ozempic-shot path for documented MASH without cirrhosis, with F2–F3 scarring and specialist involvement. That's a plan rule, not an FDA approval for Ozempic to treat MASH or prediabetes. Ask for the written criteria for your own plan and drug form.

Here's how the Medicare GLP-1 Bridge works, from CMS's own rules (checked October 17, 2026):

• Dates: July 1, 2026 through December 31, 2027.
• Medicines: Foundayo tablets, Wegovy shots and tablets, and the Zepbound KwikPen only. Ozempic, Zepbound vials, and Zepbound single-dose pens are not included.
• Who qualifies: Adults in an eligible Part D or Medicare Advantage drug plan, using the medicine for weight with ongoing structured nutrition and physical activity, with one of these at the time GLP-1 treatment started:
• BMI 35 or higher
• BMI 30 or higher plus heart failure with preserved ejection fraction, uncontrolled high blood pressure, or stage 3a+ kidney disease. CMS defines uncontrolled blood pressure as above 140 systolic or 90 diastolic despite two blood-pressure medicines.
• BMI 27 or higher plus prediabetes, a past heart attack, a past stroke, or symptomatic peripheral artery disease
• Who goes elsewhere: People with type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic MASH with moderate to advanced liver scarring (F2–F3) must use their regular Part D coverage process instead. Their plan's approval rules still apply. The same applies if the prescription is intended to reduce major cardiovascular events, even if it is also for weight. A past heart attack or stroke alone does not rule out the Bridge when the prescription is for weight management and the other rules are met.
• Prior Part D payment: A GLP-1 paid for by Part D in calendar year 2026 rules out the Bridge under the current rules. A prescription paid entirely out of pocket is different. CMS has not yet set the 2027 look-back rule (CMS Part D guidance).
• Cost: $50 for each 28- or 30-day supply. It doesn't count toward your Part D deductible or yearly out-of-pocket limit, Extra Help doesn't lower it, and coupons can't be used. Care visits and supplies can cost extra.
• How it starts: Your doctor sends a prescription and a prior authorization request. CMS says the patient and prescriber receive the decision within 72 hours of submission. Pharmacies may need to check its status (CMS pharmacy guidance).

Say you're 67, on an eligible Part D plan, and your doctor documented prediabetes, an A1C of 6.0%, and a BMI of 28 when GLP-1 treatment started. Ozempic: prediabetes alone doesn't meet its approved uses. Wegovy through the Bridge: possibly yes, for $50 a month, if your doctor submits it and you meet CMS's other rules. And if you'd rather take a pill, the Wegovy pill and Foundayo are both on the list. If treatment has since lowered your BMI or blood sugar, ask your doctor to use the records from when it began.

A Bridge denial has no appeal process. Your prescriber can resubmit corrected, updated, or additional information. Ask what was missing before paying for a different option.

One more catch: the Ozempic $25 card doesn't work with Medicare (Ozempic savings page). For every Bridge detail, see Medicare's official weight-loss drug page, our Medicare GLP-1 Bridge guide, or our Medicare Ozempic coverage guide.

Does Medicaid cover Ozempic for prediabetes?

Prediabetes alone does not establish Medicaid coverage for Ozempic. Your state program and health plan set the applicable drug rules. Coverage of weight-loss GLP-1s like Wegovy also depends on your state. Start with your state Medicaid program or the health plan that runs your drug benefits and ask for the rule for your exact diagnosis.

Our state-by-state Medicaid GLP-1 tracker links to policy evidence and dated updates; it is not a current coverage check for your plan. Ro does not accept Medicaid members for treatment, so your state plan and your own doctor are the right first stops.

How much does Ozempic cost if insurance won't pay?

Novo Nordisk, the company that makes Ozempic, offers self-pay prices through NovoCare and participating pharmacies, but a prediabetes-only prescription does not qualify. Eligible patients new to the offer pay $199 for each of their first two qualifying pen fills at the starting strengths, then $349 or $499 per pen. The Ozempic pill is $149 to $299 per 30-day bottle.

That's the catch behind the low advertised price. Novo's savings terms and NovoCare Pharmacy terms require an FDA-approved use. Prediabetes isn't one. Ask the pharmacy for its cash price outside those offers before you pay for care.

True Monthly Cost means the whole receipt, not just the sticker price. Start with these medicine costs, then add care and any extra charges (checked October 17, 2026):

Notes on the table:

• The $199 intro price is for eligible new patients at the 0.25 mg and 0.5 mg strengths, for the first two qualifying fills. At participating retail pharmacies, the offer must be redeemed and the prescription filled by December 31, 2026 (Ozempic terms, Wegovy terms). The separate NovoCare Pharmacy terms require the prescription to be written and received by December 31, 2026, and shipped by January 31, 2027.
• For the Ozempic retail offer, "new" means new to its savings offer with no participation in another Ozempic savings offer in the past 365 days. For Wegovy, it means no Wegovy injection savings redemption in that time. NovoCare requires no earlier fill of that injection through NovoCare or NovoCare Legacy.
• The $25 cards save at most $100 per month's fill, so a copay above $125 leaves you paying the difference. They require eligible commercial insurance with drug coverage; government drug plans do not qualify for these copay cards. NovoCare's separate self-pay program accepts otherwise eligible people with commercial or government insurance who pay outside their plan.
• A box of four Wegovy pens covers 28 days, and a pill bottle covers 30 days. That makes 13 shot fills 364 days and 12 pill fills 360 days, not a full 365-day year. Ozempic's offer defines a month as one pen, but the first pen can supply more than four weeks under its label. Check the pharmacy's days supply instead of assuming every pen lasts 28 days.
• The $149 pill price is for the starting strength. Ozempic's labeled ongoing tablet strengths cost $199 or $299; Wegovy's labeled maintenance-strength tablet costs $299. The 12-bottle examples use those ongoing prices, not a year at the starting price (Ozempic tablet label, Wegovy label).
• Self-pay purchases can't be sent to insurance and don't count toward your deductible or applicable out-of-pocket spending limit.
• These examples use current prices and stated fill counts. Your doctor decides your dose.

If you already have a prescriber, ask about filling through NovoCare or a participating pharmacy before adding a separate care membership.

If you use an online program, add the membership. Ro lists the same single-fill Wegovy cash prices as NovoCare, plus a separate membership: $39 for the first month, then $149 a month, or an advertised $74 a month on a 12-month plan paid up front after the first month. Twelve times the advertised $74 rate is $888; confirm the actual upfront charge and renewal date before paying (Ro pricing).

With the Wegovy shot on Ro's monthly plan, the first $199 medicine fill plus the $39 membership charge comes to $238. A later $349 fill plus a $149 membership charge comes to $498. These are medicine-plus-membership subtotals. The drug supply runs for 28 days, while membership is billed monthly.

Ro includes provider support and lab testing when needed. Its membership terms allow extra fees for consults beyond 24 a year ($15 each) and additional lab tests. Ongoing membership charges are nonrefundable. To avoid the next renewal charge, cancel at least 48 hours before the renewal date.

Compounded semaglutide is a different product: it isn't FDA-approved, and it doesn't answer an insurance question about Ozempic. If you're curious about it anyway, our compounding rules guide explains where it stands.

If your plan won't cover weight-loss medicines and your weight qualifies for Wegovy, Ro is one way to get it with a provider and ongoing support. Its treatment quiz starts that review. Ro refunds the initial purchase if no medicine is prescribed.

Start Ro's treatment quiz

Can my doctor prescribe Ozempic off-label for prediabetes?

Yes. A doctor can generally prescribe an approved medicine for a use outside its FDA label; that's called off-label prescribing. But a prescription and payment are separate. Your plan can still refuse to pay, and Novo's savings and self-pay programs require an FDA-approved use.

A prescription tells the pharmacy what your doctor ordered. Prior authorization asks whether your plan will pay for that order under its rules. Our guide to FDA indications vs. off-label use explains the difference in more detail.

Better questions to bring to your doctor:

• "Does my weight fit Wegovy's label?"
• "Does my plan cover weight-loss medicines?"
• "Should I start with a prevention program or metformin?"

How do I check my plan before paying for care?

Call the pharmacy benefits number on your insurance card, or use your member website. Ask about Ozempic for your exact diagnosis, not just whether Ozempic is "on the list." A drug can be on your plan's formulary — its list of covered drugs — and still be denied for your use.

Copy this and read it on the call:

"I'm checking Ozempic coverage before I pay for care. My doctor has documented prediabetes, and I have not been diagnosed with type 2 diabetes. Does my plan cover Ozempic for that use? Can you send me the written policy?"

If you've already been diagnosed with type 2 diabetes, say so and ask about renewal rules instead. Never change how your diagnosis is described.

Then ask these, and write down each answer:

Don't know your plan type? Your employer's benefits team can tell you. Don't know a price? Write "unconfirmed" — an unknown cost isn't zero.

You can also use the manufacturer's NovoCare coverage form, which checks Ozempic shot and pill benefits. It reports what your plan says; it doesn't approve anything. Plan-specific Ozempic guides: Aetna, Cigna, Blue Cross, CVS Caremark, Express Scripts, OptumRx.

What should I do if Ozempic was denied?

Get the denial reason in writing first. A denial can mean missing paperwork, a rule you don't meet, or a benefit your plan excludes. Each one needs a different next step.

Appeals are strongest when the denial missed something real — like a confirmed diagnosis or labs left out of the request. For prediabetes only, an Ozempic appeal is usually weak, because the plan is following its written rule. Follow the deadline and appeal steps on your denial notice. If you have a written denial with a clear reason, our appeal letter template helps you organize it. If the notice is confusing, start with plan exclusion vs. prior authorization.

What if no door is open?

The best-proven first step for prediabetes is a lifestyle program. In the Diabetes Prevention Program, the rate of new type 2 diabetes cases was 58% lower with lifestyle change and 31% lower with metformin than with placebo. The trial followed adults at high risk for about three years. The ADA says doctors can consider metformin for some higher-risk adults with prediabetes.

• A Diabetes Prevention Program: a year-long coaching program, in person or online. Medicare's program costs $0 for eligible members. Ask your plan or employer about other covered programs.
• A metformin conversation: ask your doctor whether it fits you (ADA Standards of Care, Section 3).
• At least a yearly blood sugar check: so you and your doctor see changes early. Ask which test and timing fit your risk.

This isn't second prize. For a lot of people with prediabetes, it's the plan that works.

What we actually verified

Last verified October 2026. Our source checks on October 17, 2026 covered the Ozempic and Wegovy prescribing information and official sites; Novo Nordisk's savings and self-pay terms; the six policy documents in the comparison, plus two October 2026 Medicare plan policies; CMS's Medicare GLP-1 Bridge rules; Ro's pricing, insurance, free-checker, and membership terms; and the STEP 10 and Diabetes Prevention Program results. The Express Scripts document is a November 2022 template, not a current member policy.

Prices are the public offers we read, not a personal checkout quote. We did not check your plan or test any approval — only your plan can confirm your coverage.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

See how we score and check.

Frequently asked questions

Is Ozempic FDA-approved for prediabetes?

No. Ozempic, both the shot and the pill, is approved for adults with type 2 diabetes. Neither Ozempic form has a prediabetes indication.

Will Medicare pay for Ozempic if I have prediabetes?

Usually not for prediabetes alone. Neither Medicare plan policy we checked lists it as an Ozempic approval path, though plans can review other accepted uses. Ozempic isn't part of the Medicare GLP-1 Bridge. The Bridge can cover Wegovy, the Zepbound KwikPen, and Foundayo for $50 per 28- or 30-day fill if your BMI was 27 or higher with documented prediabetes when treatment started and you meet the other CMS rules. Those include an eligible drug plan, weight-management use with structured nutrition and activity, and the Part D indication and payment-history checks explained above. Your prescriber submits the request; the result isn't automatic.

How can I get insurance to cover Ozempic for prediabetes?

Prediabetes alone does not meet the type 2 diabetes criteria in the policy table. Ask whether your plan has an off-label exception process; don't change your diagnosis to fit a rule. If a clinician documents a qualifying weight-management need, Wegovy is a separate coverage question. Ask your plan for its written rule before you pay for anything.

How much does Ozempic cost without insurance?

A prediabetes-only prescription does not qualify for Novo's advertised Ozempic offers. For eligible patients new to the offer, the price is $199 for each of the first two qualifying pen fills at the 0.25 mg or 0.5 mg strengths, then $349 or $499 per pen depending on strength. The pill costs $149 for the starting-strength bottle, then $199 or $299 per 30-day bottle at its labeled ongoing strengths. Ask the pharmacy for its cash quote outside these offers if your prescription is off-label.

$199 retail intro-offer fills must be completed by December 31, 2026. NovoCare Pharmacy instead requires the prescription to be written and received by December 31, 2026, and shipped by January 31, 2027. Both programs require an FDA-approved use.

Will trying metformin help me get Ozempic covered?

Not as a substitute for a type 2 diagnosis. Some plans use prior medicine claims to decide whether a separate authorization is needed; the CVS Caremark template does. The diabetes criteria in the comparison still require type 2 diabetes.

Can I use the Ozempic $25 savings card for prediabetes?

No. The card requires commercial insurance that covers Ozempic and a prescription for an FDA-approved use. People with Medicare, Medicaid, TRICARE, or VA coverage can't use it.

My A1C is 6.4%. Will insurance cover Ozempic?

Usually not if you've only been diagnosed with prediabetes. An A1C of 6.4% is in the prediabetes range, but it does not erase a past type 2 diabetes diagnosis or override other test results. Ask your doctor which diagnosis and lab history belong in the request; don't wait for your numbers to get worse.

Is Wegovy the same as Ozempic?

They share the same active ingredient, semaglutide, but they're different products with different approved uses and strengths. Ozempic's approved uses require type 2 diabetes. Wegovy is approved for weight management and lowering heart risk in certain adults; its injection also has a specific MASH liver indication. They are not interchangeable prescriptions.

Is the Ozempic pill easier to get covered?

The pill does not add an FDA-approved use for prediabetes. Ozempic tablets are also approved only for adults with type 2 diabetes, but a plan can use different coverage rules for the shot and pill. Ask your plan about the exact form you were prescribed.

Can my doctor appeal an Ozempic denial?

Yes, your doctor can send missing records or support an appeal through your plan's process. An appeal works best when it answers the reason given, like labs left out of the request. It can't turn prediabetes into a diabetes diagnosis.

Does Medicaid cover Ozempic for prediabetes?

Prediabetes alone does not establish coverage. Medicaid rules depend on your state, health plan, and documented diagnosis; weight-management coverage is a separate question. Call your state Medicaid plan and ask about the exact medicine and your diagnosis.

If I'm on Ozempic for diabetes and my A1C drops, will I lose coverage?

Not necessarily. Plans often look at your original diagnosis and whether the medicine is helping. Ask your doctor to include your starting labs with the renewal.

Sources

Source checks completed October 17, 2026. A check date does not change a policy's effective date or a study's publication date.

• Novo Nordisk — Ozempic cost and coverage; injection prescribing information, revised May 2026; tablet prescribing information, revised January 2026; retail savings and self-pay terms; NovoCare coverage form
• Novo Nordisk — Wegovy cost and coverage; prescribing information, revised June 2026; retail savings terms; NovoCare Pharmacy self-pay terms
• Aetna — Non-Medicare policy 2439-C P05-2025 v4, in the 2026 directory
• Cigna — IP0701 for listed employer-plan drug lists; IP0702 for individual and family plans, both effective June 15, 2026
• UnitedHealthcare — Commercial program 2026 P1332-8, effective July 1, 2026
• Express Scripts — Historical diabetes GLP-1 prior-authorization template, reviewed November 16, 2022 and revised November 30, 2022
• CVS Caremark — Antidiabetic GLP-1 criteria 5694-D P05-2025
• Medicare plan examples — Univera's 2026 Medicare Part D requirements; Mass General Brigham Medicare Group Rx (PDP) requirements, both effective October 1, 2026
• CMS — Medicare GLP-1 Bridge: information for providers; information for pharmacies; information for Part D plans; Medicare.gov weight-loss drug coverage
• McGowan BM et al. — STEP 10 primary abstract, Lancet Diabetes & Endocrinology, 2024
• American Diabetes Association — Standards of Care in Diabetes—2026: Section 2, diagnosis; Section 3, prevention
• National Institute of Diabetes and Digestive and Kidney Diseases — A1C testing and diagnosis; prescription medicines for overweight and obesity
• Diabetes Prevention Program Research Group — NEJM 2002 trial, full author manuscript; Medicare.gov Medicare Diabetes Prevention Program
• Ro — Pricing; insurance support and exclusions; free GLP-1 insurance checker; membership and refund terms
• FDA — Off-label prescribing; compounding questions and answers
• HealthCare.gov — Internal appeals

Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.